SEC Form 4 · accession 0001209191-17-021742
INVACARE CORP · IVC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert K Gudbranson
Officer — Senior VP and CFO
Period of report
Mar 16, 2017
Accepted (ET)
Mar 20, 2017 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000742112
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Mar 16, 2017 | A | 17,376 | $0.00 | A | 136,870 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3,F2 | — | holding | — | — | — | — | — | Common Shares | 184,300 | 184,300 | D |
Explanation of responses
- F1Restricted shares granted pursuant to the Invacare Corporation 2013 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These shares vest in 1/3 annual increments over three years commencing on May 15, 2018.
- F2No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
- F3The reporting person holds previously reported options to buy 184,300 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between April 1, 2008 and March 18, 2013, at exercise prices between $13.37 to $25.79 per share, will expire between April 1, 2018 and March 18, 2023, and became or will become exercisable between March 31, 2009 and March 31, 2017.